Glaucoma Surgery Devices Market: Market Size & Forecast 2026

The global glaucoma surgery devices market encompasses a range of products designed to manage intraocular pressure, including conventional surgical instruments, glaucoma drainage implants, and minimally invasive devices. The market reached approximately $1.62 billion in 2025, reflecting steady demand from ophthalmologists and healthcare systems seeking effective treatments for this progressive optic neuropathy. Growth continues as rising glaucoma prevalence and technological improvements expand treatment options beyond medication to include durable surgical interventions.

• •Traditional trabeculectomy and tube shunt procedures remain important despite the rise of minimally invasive alternatives
• •Microinvasive glaucoma surgery devices have gained significant market share since their introduction in the early 2010s
• •Market size of $1.62 billion in 2025 with 4.7% CAGR projected through the early 2030s

The increasing global burden of glaucoma, estimated to affect over 80 million people worldwide, drives sustained demand for surgical intervention options. An aging demographic profile correlates strongly with higher glaucoma incidence, as age remains the primary risk factor alongside family history and certain medical conditions. Additionally, the limitations of topical medications, including compliance challenges, side effects, and diminishing efficacy over time, push patients and physicians toward surgical solutions that offer more durable pressure control.

• •Aging populations in developed and developing countries contribute to rising glaucoma diagnosis rates
• •Advances in microsurgical techniques and implant materials improve surgical outcomes and reduce complications
• •Growing adoption of MIGS procedures among ophthalmologists expands the addressable patient pool

The market is typically segmented by device type, including MIGS devices, traditional glaucoma drainage devices, and surgical instruments and accessories. North America commands the largest share due to advanced healthcare infrastructure, higher healthcare spending, and early adoption of innovative surgical technologies. Europe represents the second-largest market with strong demand from countries with aging populations, while the Asia-Pacific region is expected to see the fastest growth as healthcare access improves and glaucoma awareness rises in populous nations.

• •MIGS segment is growing fastest as these procedures offer shorter recovery times and better safety profiles
• •North America's market leadership stems from favorable reimbursement policies and presence of major device manufacturers
• •Asia-Pacific expansion is driven by improving diagnostic capabilities and increasing healthcare expenditure in China and India

What are the recent trends and outlook?

The market outlook centers on continued expansion of MIGS procedures, which now represent a substantial portion of new glaucoma surgical interventions performed globally. Robotic assistance and digital imaging guidance are emerging technologies that may further refine surgical precision and outcomes in complex glaucoma cases. Future growth will likely be supported by pipeline devices targeting earlier-stage disease, favorable clinical trial results for novel drug-device combinations, and increasing emphasis on cost-effective solutions for healthcare systems managing chronic eye diseases.

• •MIGS procedures are projected to capture an increasing share of glaucoma surgeries as clinical evidence accumulates
• •Integration of digital technologies and navigation systems into glaucoma surgical workflows is advancing
• •Pipeline development focuses on devices suitable for earlier disease stages to delay progression before significant vision loss occurs